AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 29 filers reported holding AGILE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,000 | -40.0% | 41,277 | +32.0% | 0.00% | – |
Q4 2021 | $15,000 | -65.1% | 31,277 | -30.6% | 0.00% | – |
Q3 2021 | $43,000 | -10.4% | 45,077 | +23.9% | 0.00% | – |
Q2 2021 | $48,000 | +77.8% | 36,377 | +178.8% | 0.00% | – |
Q1 2021 | $27,000 | -89.0% | 13,046 | -84.8% | 0.00% | – |
Q4 2020 | $246,000 | -5.4% | 85,700 | +0.0% | 0.00% | -100.0% |
Q3 2020 | $260,000 | +3614.3% | 85,679 | +3306.7% | 0.00% | – |
Q2 2020 | $7,000 | -95.9% | 2,515 | -97.2% | 0.00% | -100.0% |
Q1 2020 | $169,000 | +36.3% | 90,601 | +82.2% | 0.00% | 0.0% |
Q4 2019 | $124,000 | +275.8% | 49,713 | +80.4% | 0.00% | – |
Q3 2019 | $33,000 | +1550.0% | 27,563 | +2135.4% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 1,233 | +23.3% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 1,000 | -16.7% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 1,200 | -61.3% | 0.00% | – |
Q3 2018 | $1,000 | -75.0% | 3,100 | -59.7% | 0.00% | – |
Q2 2018 | $4,000 | -20.0% | 7,700 | +332.1% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 1,782 | -1.9% | 0.00% | – |
Q4 2017 | $5,000 | – | 1,817 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
Summit Global Investments | 110,100 | $146,000 | 0.01% |
Founders Capital Management | 10,000 | $13,000 | 0.01% |